CYP51: A major drug target in the cytochrome P450 superfamily.

RCMI Coordinating Center (RCMI CC)

CYP51: A major drug target in the cytochrome P450 superfamily.

Lepesheva GI, Hargrove TY, Kleshchenko Y, Nes WD, Villalta F, Waterman MR. CYP51: A major drug target in the cytochrome P450 superfamily. Lipids. 2008 Dec; 43(12):1117-25.

View in: PubMed

subject areas

Animals
Azoles
Cytochrome P-450 Enzyme System
Drug Design
Humans
Microbial Sensitivity Tests
Molecular Structure
Protozoan Proteins
Sterols
Substrate Specificity
Trypanosoma

authors with profiles

Fernando Villalta

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support